Spironolactone
Product Images NDC 70934-368

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 70934-368). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Denton Pharma, Inc. Dba Northwind Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (70934 368 30 Rev A 02 20 1)

This is a prescription drug called Spironolactone Tablet, USP. It comes in a package of 30 tablets, each containing 50mg of the active ingredient. The NDC code is 70934-368-30. The rest of the text appears to be incomplete or unreadable.*

FDA Label Image

Figure 1 (Spironolactone Figure 1)

This appears to be a statistical analysis output evaluating survival rates over time. The "Log-rank p" value of less than 0.001 suggests a statistically significant difference in survival between groups being compared. The intervals of time measured appear to be in months from 12 to 48. However, without additional context or data, the description is limited.*

FDA Label Image

Figure 2 (Spironolactone Figure 2)

This seems to be a chart showing results of a study or experiment comparing the effectiveness of Spironolactone and Placebo. The top row displays subgroup categories and the columns show different measurements. However, without further context, it is difficult to draw more specific conclusions.*

FDA Label Image

Chemical Structure (Spironolactone Structure Image)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.